Registration for PeproTech.com is no longer available. To order your PeproTech products online, register or logon to ThermoFisher.com.

Resources & Support

References

First Author
Iriguchi, S
Title
A clinically applicable and scalable method to regenerate T-cells from iPSCs for off-the-shelf T-cell immunotherapy.
Citation
Nature communications; 2021 Jan 18; 12(1) pg430
PubMed ID
33462228
Show Usages
Product Cited
Cross-Reactivity
Applications
300-18
Human
in vitro
300-19
Human
in vitro
300-28A
Human
in vitro
200-02
Human
in vitro
200-15
Human
in vitro
200-21
Human
in vitro
310-23
Human
in vitro
First Author
Hong, S P
Title
Distinct fibroblast subsets regulate lacteal integrity through YAP/TAZ-induced VEGF-C in intestinal villi
Citation
Nature communications; 2020 Aug 14; 11(1) pg4102
PubMed ID
32796823
Show Usages
Product Cited
Cross-Reactivity
Applications
120-16
Human
in vitro
310-23
Human
in vitro
AF-450-02
Human
in vitro
200-38
Human
in vitro
First Author
Li, J
Title
Activation of DR3 signaling causes loss of ILC3s and exacerbates intestinal inflammation.
Citation
Nature Communications;2019 7 29; 10(1) pg3371
PubMed ID
31358760
Show Usages
Product Cited
Cross-Reactivity
Applications
310-23
Human
in vitro
First Author
Hedl, M
Title
A TNFSF15 disease-risk polymorphism increases pattern-recognition receptor-induced signaling through caspase-8-induced IL-1.
Citation
Proceedings of the National Academy of Sciences of the United States of America; 2014 Sep 16; 111(37) pg13451-6
PubMed ID
25197060
Show Usages
Product Cited
Cross-Reactivity
Applications
310-23
Human
in vitro
900-K290
Human
ELISA
First Author
McLaren, J E
Title
The TNF-like protein 1A-death receptor 3 pathway promotes macrophage foam cell formation in vitro.
Citation
Journal of immunology (Baltimore, Md. : 1950); 2010 May 15; 184(10) pg5827-34
PubMed ID
20410491
Show Usages
Product Cited
Cross-Reactivity
Applications
300-02
Human
in vitro
310-23
Human
in vitro
showing 5 of 5